Lavender improves fatigue symptoms in multiple sclerosis patients: A double-blind, randomized controlled trial.

Najmeh Motaghi, Haleh Tajadini, Kaveh Shafiei, Fariba Sharififar, Mehdi Ansari, Hamid Sharifi, Zarrin Sarhadynejad, Fateme Tavakoli-Far, Hoda Kamali, Ehsan Amiri-Ardekani

Journal: Multiple sclerosis and related disorders 2022;65():104000

PMID: 35803088

Abstract

BACKGROUND

Fatigue is one of the most common complications of Multiple Sclerosis (MS) patients. Several pharmacological and non-pharmacological interventions have been recommended to control this complication. Lavender is one of the plants considered by Persian Medicine (PM) and recommended by scholars of past centuries in the treatment of neurological diseases. This study aimed to investigate the efficacy of lavender capsule on improving fatigue symptoms in MS patients.

MATERIAL AND METHODS

In a double-blind, controlled trial, using a computer block randomization approach, 48 confirmed MS patients with eligibility criteria of being 18 years or older, Modified Fatigue Impact Scale (MFIS) ≥25, relapsing-remitting MS patients, EDSS ≤6, not pregnant, not breastfeeding, and not suffering from other diseases that cause fatigue, were randomized to receive capsules containing 600mg of lavender flowers as the intervention group or capsules containing 600mg cornstarch as the control group. Patients were randomized after completing the MFIS and were asked to take one capsule three times daily for 60 days. The MFIS again checked to assess the impact of two interventions. Analysis of Covariance (ANCOVA) was used to assess the impact of two interventions.

RESULTS

24 patients included in each group. The mean (standard deviation) of MFIS was 40.56 (7.63) in the intervention and 41.43 (7.89) in the control groups (p=0.706) before the intervention. However, there was a significant reduction (p0.001˂) in the intervention group, 7.04 (4.91) compared to the control group, 38.17 (9.78) after the intervention.

CONCLUSION

In comparison to cornstarch capsules, consuming the capsules of lavender flowers decreased the MFIS in MS patients.

Copyright © 2022 Elsevier B.V. All rights reserved.

Address: Neuroscience Research Center, Institute of Neuropharmacology, Kerman university of Medical Sciences, Kerman, Iran; Department of Traditional Medicine, Faculty of Persian Medicine, Kerman University of Medical Sciences, Kerman, Iran.; Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: [email protected].; Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.; Herbal and traditional Medicines Research Center, Faculty of Pharmacy, Kerman university of Medical Sciences, Kerman, Iran.; Department of Drug and Food Control, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance,  Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Herbal and traditional Medicines Research Center, Faculty of Pharmacy, Kerman university of Medical Sciences, Kerman, Iran; Department of Pharmacy Medicine, Faculty of Persian Medicine, Kerman University of Medical Sciences, Kerman, Iran.; Faculty of Pharmacy, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran; Scientific Association of Indigenous Knowledge, Shiraz University of Medical Sciences, Shiraz, Iran.; Department of Phytopharmaceuticals (Traditional Pharmacy), Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran; Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: [email protected].

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.